Compass Financial Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Compass Financial Management's VRTX Position: Q3 2026 in Review
Compass Financial Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.98% in Q3 2026, buying an estimated $512 and bringing the position to 103 shares worth $53.8K. The position accounts for 0.01% of the portfolio, ranked #721.
Compass Financial Management first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,798 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Compass Financial Management held 103 shares of Vertex Pharmaceuticals worth $53.8K as of Q3 2026.
- Compass Financial Management bought 1 Vertex Pharmaceuticals share in Q3 2026, an estimated $512.
- Vertex Pharmaceuticals made up 0.01% of Compass Financial Management's portfolio in Q3 2026, its #721 holding.
- Compass Financial Management first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 1,798 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.